TGFB1 and pulmonary fibrosis: Prior to the COVID-19 pandemic, there was strong evidence that TGF-β1 is a key driver in the pathophysiology of the acute respiratory distress syndrome (ARDS) and in chronic fibrotic lung diseases such as idiopathic pulmonary fibrosis (IPF).